Amikacin

Kathryn Dzintars, Pharm.D., BCPS
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.
Amikacin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Amikacin sulfate indicated in the short-term treatment of serious infections due to susceptible organisms
  • Bacterial septicemia (including neonatal sepsis)
  • Respiratory tract infections
  • Bone and joint infections
  • Central nervous system infections
  • Skin and soft tissue infections (including burns, postoperative infections)
  • Intra-abdominal infections
  • Complicated and recurrent urinary tract infections.

NON-FDA APPROVED USES

  • Pneumonia, Hospital-Acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third-/fourth-generation cephalosporin)
  • Tuberculosis
  • Non-tubercular mycobacterial (NTM) infections, MAI
  • Nocardia
  • Aerosolized amikacin has been used for the management of cystic fibrosis exacerbations

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  • Amikacin sulfate indicated in the short-term treatment of serious infections due to susceptible organisms
  • Bacterial septicemia (including neonatal sepsis)
  • Respiratory tract infections
  • Bone and joint infections
  • Central nervous system infections
  • Skin and soft tissue infections (including burns, postoperative infections)
  • Intra-abdominal infections
  • Complicated and recurrent urinary tract infections.

NON-FDA APPROVED USES

  • Pneumonia, Hospital-Acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third-/fourth-generation cephalosporin)
  • Tuberculosis
  • Non-tubercular mycobacterial (NTM) infections, MAI
  • Nocardia
  • Aerosolized amikacin has been used for the management of cystic fibrosis exacerbations

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: January 12, 2020